Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles

European Journal of Medicinal Chemistry

Volumn 43, Issue 11, 2008, Pages 2568-2578

  Alper Hayta, Sabiha ^a   Arisoy, Mustafa ^a   Temiz Arpaci, Özlem ^a   Yildiz, Ilkay ^a   Aki, Esin ^a   Özkan, Semiha ^b   Kaynak, Fatma ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Antibacterial activity; Antifungal activity; Benzofuran; Benzoxazole; Pharmacophore analysis

Indexed keywords

5 [(2 BENZOFURYL)CARBOXAMIDO]BENZOXAZOLE; BENZOXAZOLE DERIVATIVE; FLUCONAZOLE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION;

AMIDES; ANTI-BACTERIAL AGENTS; BENZOFURANS; BENZOXAZOLES; MICROBIAL VIABILITY; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 54049132967     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.12.019     Document Type: Article

References (49)

1. Livermore D.M. Int. J. Antimicrob. Agents 16 (2000) 3-10
2. Poole K. Curr. Opin. Microbiol. 4 5 (2001) 500-508
3. Abbanat D., Macielag M., and Bush K. Expert. Opin. Investig. Drugs 12 3 (2003) 379-399
4. Metwally K.A., Abdel-Aziz L.M., Lashine E.M., Husseiny M.I., and Badawy R. Bioorg. Med. Chem. 14 24 (2006) 8675-8682
5. Yoneyama H., and Katsumata R. Biosci. Biotechnol. Biochem. 70 5 (2006) 1060-1075
6. Alanis J.A. Arch. Med. Res. 36 (2005) 667-671
7. Khan M.W., Alam M.J., Rashid M.A., and Chowdhury R. Bioorg. Med. Chem. 13 16 (2005) 4796-4805
8. Fukai T., Oku Y., Hano Y., and Terada S. Planta Med. 70 7 (2004) 685-687
9. Jang J.H., Kanoh K., Adachi K., and Shizuri Y. J. Antibiot. 59 7 (2006) 428-431
10. Rida S.M., El-Hawashi S.A., Fahmy H.T., Hazza A.A., and El-Meligy M.M. Arch. Pharm. Res. 29 1 (2006) 16-25
11. Rida S.M., El-Hawashi S.A., Fahmy H.T., Hazza A.A., and El-Meligy M.M. Arch. Pharm. Res. 29 10 (2006) 826-833
12. Fukai T., Kaitou K., and Terada S. Fitoterapia 76 (2005) 708-711
13. Prudhomme M., Guyot J., and Jeminet G. J. Antibiot. 39 (1986) 934-937
14. Martin D.D., Kotecha N.R., Ley S.V., Maqntegani S., Menendes J.C., Organ H.M., and White A.D. Tetrahedron 48 37 (1992) 7899-7938
15. Ören I., Temiz O., Yalcin I., Sener E., Akin A., and Ucarturk N. Arzneim.-Forsch./Drug Res. 47 12 (1997) 1393-1397
16. Temiz O., Ören I., Yalcin I., Sener E., and Uçartürk N. Farmaco 53 (1998) 337-341
17. Ören I., Temiz O., Yalcin I., Sener E., and Altanlar N. Eur. J. Pharm. Sci. 7 (1998) 153-160
18. Aki-Sener E., Temiz-Arpaci O., Yalcin I., and Altanlar N. Farmaco 55 (2000) 397-405
19. Temiz-Arpaci O., Ören I., and Altanlar N. Farmaco 57 (2002) 175-181
20. Temiz-Arpaci O., Aki-Sener E., Yalcin I., and Altanlar N. Arch. Pharm. 6 (2002) 283-288
21. Temiz-Arpaci O., Aki-Sener E., Yalcin I., and Altanlar N. Farmaco 57 (2002) 771-775
22. Yildiz-Ören I., Tekiner B., Yalcin I., Temiz-Arpaci O., Aki-Sener E., and Altanlar N. Arch. Pharm. 337 7 (2004) 402-410
23. Yildiz-Ören I., Yalcin I., Aki-Sener E., and Ucarturk N. Eur. J. Med. Chem. 39 (2004) 291-298
24. Temiz-Arpaci O., Özdemir A., Yalcin I., Yildiz I., Aki-Sener E., and Altanlar N. Arch. Pharm. 338 2-3 (2005) 105-111
25. Turan-Zitoni G., Demirayak S., Özdemir A., Kaplanci{dotless}kli{dotless} Z.A., and Yildiz M.T. Eur. J. Med. Chem. 39 3 (2004) 267-272
26. Vinsova J., Horak V., Buchta V., and Kaustova J. Molecules 10 (2005) 783-793
27. Balani S.K., Pitzenberger S.M., Kauffman L.R., Arison B.H., Ramjit H.G., Goldman M.E., O'Brien J.A., King J.D., Hoffman J.M., Rooney C.S., and Theoharides A.D. Drug Metab. Dispos. 20 6 (1992) 869-876
28. Houpis I.N., Molina A., Lynch J., Reamer R.A., Volante R.P., and Reider P.J. J.Org. Chem. 58 (1993) 3176-3178
29. Saari W.S., Wai J.S., Fisher T.E., Thomas C.M., Hofmann J.M., Roomey C.S., Smith A.O., Jones J.H., Bamberger D.L., Goldman M.E., O'Brien J.A., Nunberg J.H., Quintero J.C., Schleif Q.A., Emini E.A., and Anderson P.S. J. Med. Chem. 35 (1992) 3792-3802
30. Davey R.T., Dewar R.L., Reed G.F., Vasudevachari M.B., Polis M.A., Kovacs J.A., Fallon J., Walker R.E., Masur H., Haniwich S.E., O'Neil D.G., Decker M.R., Metcalf J.A., Deloria M.A., Laskin O.L., Salzman N., and Lone H.C. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5608-5612
31. Akbay A., Ören I., Temiz-Arpaci O., Aki-Sener E., and Yalcin I. Arzneim.-Forsch. 53 4 (2003) 266-271
32. Pi{dotless}nar A., Yurdakul P., Yildiz-Ören I., Temiz-Arpaci O., Acan N.L., Aki-Sener E., and Yalcin I. Biochem. Biophys. Res. Commun. 317 2 (2004) 670-674
33. Temiz-Arpaci O., Tekiner-Gulbas B., Yildiz I., Aki-Sener E., and Yalcin I. Bioorg. Med. Chem. 13 (2005) 6354-6359
34. Kim J.S., Sun Q., Gatto B., Yu C., Liu A., Liu L.F., and LaVoie E.J. Bioorg. Med. Chem. 4 4 (1996) 621-630
35. Ueki M., Ueno K., Miyadoh S., Abe K., Shibata K., Tanguchi M., and Oi S. J. Antibiot. 46 (1993) 1089-1094
36. Ueki M., and Taniguchi M. J Antibiot. 50 (1997) 788-790
37. Rida S.M., Ashour F.A., El-Hawash S., El-Semary M., Badr M.H., and Shalaby M.A. Eur. J. Med. Chem. 40 9 (2005) 949-959
38. Varga A., Aki-Sener E., Yalcin I., Temiz-Arpaci O., Tekiner-Gülbaş B., Cherepnev G., and Molnar J. In Vivo 19 6 (2005) 1087-1092
39. Tekiner-Gulbas B., Temiz-Arpaci O., Yildiz I., and Altanlar N. Eur. J. Med. Chem. 42 10 (2007) 1293-1299
40. Graybill J.R. Clin. Infect. Dis. 22 2 (1996) 166-178
41. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, M2-A9 (2006), Clinical and Laboratory Standarts Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
42. Clinical and Laboratory Laboratory Standards Institute (CLSI) (formerly NCCLS). Performance Standards for Antimicrobial Susceptibility Testing; 16th Informational Supplement. CLSI M100-S16 (2006), Clinical and Laboratory Standarts Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
43. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS). Reference method for broth dilution antifungal susceptibility testing yeast; approved standard, M27-A (2006), Clinical and Laboratory Standarts Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
44. Accelrys Inc., Catalyst 4.9, 2004.
45. Smellie A., Kahn S.D., and Teig S.L. J. Chem. Inf. Comput. Sci. 35 (1995) 285-294
46. Smellie A., Kahn S.D., and Teig S.L. J. Chem. Inf. Comput. Sci. 35 (1995) 295-304
47. Smellie A., Teig S.L., and Towbin P. J. Comput. Chem. 16 (1994) 171-187
48. Greene J., Kahn S., Savoj H., Sprague P., and Teig S. J. Chem. Inf. Comput. Sci. 34 (1994) 1297-1308
49. Barnum D., Greene J., Smellie A., and Sprague P. J.Chem. Inf. Comput. Sci. 36 (1996) 563-571